Rion Co., Ltd. (JP:6823)
:6823
Want to see JP:6823 full AI Analyst Report?
6823 Stock Chart & Stats
¥2691.00
-¥68.00(-2.64%)
At close: 4:00 PM EST
¥2691.00
-¥68.00(-2.64%)
Day’s Range― - ―
52-Week Range¥2,401.00 - ¥4,160.00
Previous CloseN/A
Volume32.10K
Average Volume (3M)26.46K
Market Cap
¥47.47B
Enterprise Value¥37.98B
Total Cash (Recent Filing)¥6.16B
Total Debt (Recent Filing)¥1.73B
Price to Earnings (P/E)15.0
Beta1.12
Next Earnings
Jul 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.93%
Share Statistics
EPS (TTM)247.93
Shares Outstanding12,347,700
10 Day Avg. Volume21,140
30 Day Avg. Volume26,463
Financial Highlights & Ratios
PEG Ratio0.59
Price to Book (P/B)0.96
Price to Sales (P/S)1.17
P/FCF Ratio9.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)283.9
Revenue Forecast (FY)¥30.00B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageRion's near-zero total debt and steadily compounding equity provide a durable financial buffer versus cyclicality. Low leverage reduces default and financing risk, preserves capacity for capital spending or M&A, and supports dividends or buybacks without stressing cash flow in downturns.
Steady Revenue Growth With Recent AccelerationMulti-year revenue expansion, capped by a strong ~24% uptick in 2026, indicates persistent demand for Rion's measurement and hearing products. Durable top-line growth supports scale, underpins investment in R&D and service offerings, and reduces reliance on single-period performance.
Improving Operating And Free Cash FlowRising operating and free cash flow over the period strengthens internal funding for capex, product development, and shareholder returns. Consistent positive cash generation enhances financial flexibility and supports investment in after-sales services and software, which can deepen customer relationships.
Bears Say
Free Cash Flow VolatilityMaterial swings in free cash flow reduce predictability for capital allocation and raise the risk that funding for R&D, service expansion, or dividends could be constrained in weaker years. Volatility suggests working-capital or timing risks that can impair long-term planning.
Margin Visibility And Cost Pressure SignsA drop in gross profit dollars despite rising revenue points to input-cost or mix pressures that could compress margins sustainably. Limited margin transparency increases uncertainty about future profitability and the ability to convert revenue growth into durable earnings expansion.
Moderate Returns On EquityROE under 10% indicates moderate capital efficiency; while improving, it suggests the company may not extract high returns from equity relative to higher-efficiency peers. That could limit long-term shareholder return potential absent higher margin or faster asset turnover.
Rion Co., Ltd. News
6823 FAQ
What was Rion Co., Ltd.’s price range in the past 12 months?
Rion Co., Ltd. lowest stock price was ¥2401.00 and its highest was ¥4160.00 in the past 12 months.
What is Rion Co., Ltd.’s market cap?
Rion Co., Ltd.’s market cap is ¥47.47B.
When is Rion Co., Ltd.’s upcoming earnings report date?
Rion Co., Ltd.’s upcoming earnings report date is Jul 24, 2026 which is in 34 days.
How were Rion Co., Ltd.’s earnings last quarter?
Rion Co., Ltd. released its earnings results on Apr 28, 2026. The company reported ¥88.99 earnings per share for the quarter, beating the consensus estimate of N/A by ¥88.99.
Is Rion Co., Ltd. overvalued?
According to Wall Street analysts Rion Co., Ltd.’s price is currently Overvalued.
Does Rion Co., Ltd. pay dividends?
Rion Co., Ltd. pays a Semiannually dividend of ¥45 which represents an annual dividend yield of 2.93%. See more information on Rion Co., Ltd. dividends here
What is Rion Co., Ltd.’s EPS estimate?
Rion Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rion Co., Ltd. have?
Rion Co., Ltd. has 12,347,700 shares outstanding.
What happened to Rion Co., Ltd.’s price movement after its last earnings report?
Rion Co., Ltd. reported an EPS of ¥88.99 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.772%.
Which hedge fund is a major shareholder of Rion Co., Ltd.?
Currently, no hedge funds are holding shares in JP:6823
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rion Co., Ltd.
Rion Co., Ltd. is a Japanese enterprise specializing in the production, distribution, and upkeep of a diverse range of precision equipment. Their offerings include a comprehensive suite of audiological devices, such as various analog and digital behind-the-ear (BTE) hearing aids, including trimmer digital and waterproof models, alongside ready-made and custom in-the-ear (ITE) devices, and analog body aid instruments. Complementing these are medical apparatus like audiometers and otoacoustic emission (OAE) screeners. The company also provides an array of acoustic and seismic measurement tools, encompassing sound level meters, vibration sensors, seismographs, frequency analysis equipment, microphones, accelerometers, and recording devices. Furthermore, Rion develops advanced particle detection systems, including instruments for airborne, liquid-borne, and viable particle counting. These sophisticated products serve critical applications in sectors such as environmental management, electronics, semiconductor fabrication, the pharmaceutical industry, and food production. Founded in 1944 and headquartered in Kokubunji, Japan, the firm operated under the name Kobayashi-Riken Seisakusho Ltd. until its rebranding as Rion Co., Ltd. in 1960.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---